Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024:74:213-238.
doi: 10.1007/978-3-031-65944-7_8.

Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors

Affiliations
Review

Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors

Pooja Kamal Melwani et al. Results Probl Cell Differ. 2024.

Abstract

Tumor associated macrophages (TAMs) are one of the most prominent immune cells in the breast tumor microenvironment (TME). TAMs are categorised into classically activated anti-tumorigenic M1 and alternatively activated pro-tumorigenic M2 macrophages. TAMs are known to promote cancer pathogenesis by facilitating cancer cell and cancer stem cell growth, angiogenesis, immune evasion, invasion, and migration. Consequently, TAMs drive cancer progression towards metastasis. This chapter describes the role of TME in driving monocyte recruitment and polarization toward the M2 phenotype. We also illustrate the modalities of intercellular networking such as paracrine signaling, exosomes, and tunneling nanotubes (TNTs) that TAMs and cancer cells employ within TME to communicate with each other and with other cells of TME to facilitate the dynamic process of cancer progression. Finally, we discuss the clinical implications of TAMs in breast cancer and potential therapeutic strategies targeting TAM recruitment, polarization, and TAM-mediated immune evasion for effective cancer therapy.

Keywords: Breast cancer; Intercellular communication; Metastasis; Tumor associated macrophages; Tumor microenvironment; Tunneling nanotubes.

PubMed Disclaimer

References

    1. Abraham D et al (2010) Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma. Int J Cancer 126(6):1339–1352 - PubMed - PMC
    1. Allavena P et al (2005) Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. Cancer Res 65(7):2964–2971 - PubMed
    1. Allavena P, Digifico E, Belgiovine C (2021) Macrophages and cancer stem cells: a malevolent alliance. Mol Med 27(1):121 - PubMed - PMC
    1. Allison E et al (2023) Breast cancer survival outcomes and tumor-associated macrophage markers: a systematic review and meta-analysis. Oncol Ther 11(1):27–48 - PubMed
    1. Amintas S et al (2020) Circulating tumor cell clusters: united we stand divided we fall. Int J Mol Sci 21(7)

LinkOut - more resources